Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 213
Filter
Add more filters

Publication year range
1.
Int J Mol Sci ; 25(14)2024 Jul 11.
Article in English | MEDLINE | ID: mdl-39062883

ABSTRACT

Pyridine, a compound with a heterocyclic structure, is a key player in medicinal chemistry and drug design. It is widely used as a framework for the design of biologically active molecules and is the second most common heterocycle in FDA-approved drugs. Pyridine is known for its diverse biological activity, including antituberculosis, antitumor, anticoagulant, antiviral, antimalarial, antileishmania, anti-inflammatory, anti-Alzheimer's, antitrypanosomal, antimalarial, vasodilatory, antioxidant, antimicrobial, and antiproliferative effects. This review, spanning from 2022 to 2012, involved the meticulous identification of pyridine derivatives with antiproliferative activity, as indicated by their minimum inhibitory concentration values (IC50) against various cancerous cell lines. The aim was to determine the most favorable structural characteristics for their antiproliferative activity. Using computer programs, we constructed and calculated the molecular descriptors and analyzed the electrostatic potential maps of the selected pyridine derivatives. The study found that the presence and positions of the -OMe, -OH, -C=O, and NH2 groups in the pyridine derivatives enhanced their antiproliferative activity over the cancerous cellular lines studied. Conversely, pyridine derivatives with halogen atoms or bulky groups in their structures exhibited lower antiproliferative activity.


Subject(s)
Antineoplastic Agents , Cell Proliferation , Pyridines , Pyridines/chemistry , Pyridines/pharmacology , Humans , Cell Proliferation/drug effects , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Structure-Activity Relationship , Cell Line, Tumor
2.
Nephrol Dial Transplant ; 38(6): 1552-1559, 2023 05 31.
Article in English | MEDLINE | ID: mdl-36323457

ABSTRACT

BACKGROUND: Diabetes is a risk factor for cancer in the general population. However, few data are available on the association between post-transplant diabetes mellitus (PTDM) and cancer after transplantation. METHODS: We analyzed this issue in a Spanish cohort of patients without diabetes before transplantation. PTDM was diagnosed with consensus criteria at 12 months after transplantation and 12 months before the diagnosis of cancer. The association between PTDM and cancer (overall and specific types) was evaluated with regression analysis. RESULTS: During a follow-up of 12 years (interquartile range 8-14), 85 cases of 603 developed cancer (829/100 000/year) and 164 (27%) PTDM. The most frequent cancers were renal cell cancer (RCC) n = 15, 146/cases/100 000/year), lung (n = 12, 117/cases/100 000/year), colon (n = 9, 88/cases/100 000/year) and prostate (n = 9, 88/cases/100 000/year). In logistic regression, PTDM was not associated with cancer. Eight of the 164 patients with PTDM (4.9%) vs 7 of the 439 without PTDM developed RCC (1.6%) (P = .027). In multivariate analysis, PTDM was independently associated with RCC [odds ratio (OR) 2.92, confidence interval (CI) 1.03-8.27], adjusting for smoking (OR 4.020, 95% CI 1.34-12.02) and other covariates. PTDM was not associated with other types of cancer. CONCLUSIONS: Patients with PTDM must be considered a population at risk for RCC and accordingly, the subject of active surveillance.


Subject(s)
Carcinoma, Renal Cell , Diabetes Mellitus , Kidney Neoplasms , Kidney Transplantation , Male , Humans , Kidney Transplantation/adverse effects , Carcinoma, Renal Cell/etiology , Carcinoma, Renal Cell/complications , Diabetes Mellitus/epidemiology , Diabetes Mellitus/etiology , Diabetes Mellitus/diagnosis , Risk Factors , Kidney Neoplasms/epidemiology , Kidney Neoplasms/etiology , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Retrospective Studies
3.
Chem Biodivers ; 20(5): e202200972, 2023 May.
Article in English | MEDLINE | ID: mdl-37058554

ABSTRACT

We present the synthesis and characterization of organic Salphen compounds containing bromine substituents at the para/ortho-para positions, in their symmetric and non-symmetric versions, and describe the X-ray structure and full characterization for the new unsymmetrical varieties. We report for the first time antiproliferative activity in metal-free brominated Salphen compounds, by evaluations in four human cancer cell lines, cervix (HeLa), prostate (PC-3), lung (A549) and colon (LS 180) and one non-cancerous counterpart (ARPE-19). We assessed in vitro cell viability against controls using the MTT assay ((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)) and determined the concentration required for 50 % growth inhibition (IC50 ), together with their selectivity vs. non-cancerous cells. We found promising results against prostate (9.6 µM) and colon (13.5 µM) adenocarcinoma cells. We also found a tradeoff between selectivity (up to 3-fold vs. ARPE-19) and inhibition, depending upon the symmetry and bromine-substitution of the molecules, showing up to 20-fold higher selectivity vs. doxorubicin controls.


Subject(s)
Antineoplastic Agents , Bromine , Male , Female , Humans , Bromine/pharmacology , HeLa Cells , Phenylenediamines/pharmacology , Antineoplastic Agents/chemistry , Cell Proliferation , Cell Line, Tumor , Drug Screening Assays, Antitumor , Structure-Activity Relationship , Molecular Structure
4.
Molecules ; 28(16)2023 Aug 17.
Article in English | MEDLINE | ID: mdl-37630347

ABSTRACT

The formose reaction is an autocatalytic series of aldol condensations that allows one to obtain monosaccharides from formaldehyde. The formose reaction suffers from a lack of selectivity, which hinders practical applications at the industrial level. Over the years, many attempts have been made to overcome this selectivity issue, with modest results. Heterogeneous porous catalysts with acid-base properties, such as Metal-Organic Frameworks (MOFs), can offer advantages compared to homogeneous strong bases (e.g., calcium hydroxide) for increasing the selectivity of this important reaction. For the very first time, four different Zeolite Imidazolate Frameworks are presented in this work as catalysts for the formose reaction in liquid phase, and their catalytic performances were compared with those of the typical homogeneous catalyst (i.e., calcium hydroxide). The heterogeneous nature of the catalysis, the possible contribution of leached metal or linkers to the solution, and the stability of the materials were investigated. The porous structure of these solids and their mild basicity make them suitable for obtaining enhanced selectivity at 30% formaldehyde conversion. Most of the MOFs tested showed low structural stability under reaction conditions, thereby indicating the need to search for new MOF families with higher robustness. However, this important result opens the path for future research on porous heterogeneous basic catalysts for the formose reaction.

5.
Int J Environ Health Res ; 33(12): 1591-1603, 2023 Dec.
Article in English | MEDLINE | ID: mdl-35951754

ABSTRACT

Propolis is a resinous substance collected by bees (Apis mellifera). It is used for its biological properties. This natural product is available as a safe therapeutic option. Herein, we report the antiviral effects of brown propolis extract from Mexico and green and red propolis extracts from Brazil, as well as their phenolic compounds (quercetin, caffeic acid, and rutin) in preventing infection of MRC-5 cells by HCoV-229E. Normal human fibroblast lung cells (MRC-5) were used to determine the cytotoxicity of the compounds. All samples studied showed antiviral activity. Green and brown propolis extracts, and quercetin exhibited the best EC50 values with values of 19.080, 11.240, and 77.208 µg/mL against HCoV-229E, respectively, and with TC50 of 62.19, 29.192, and 298 µg/mL on MRC-5 cells, respectively. These results are the first in vitro study of the effects of propolis on HCoV-229E and provide the basis for the development of natural formulations against other coronavirus strains.


Subject(s)
Coronavirus 229E, Human , Propolis , Humans , Animals , Propolis/pharmacology , Brazil , Quercetin/pharmacology , Mexico , Phenols/pharmacology , Antiviral Agents/pharmacology
6.
Int J Mol Sci ; 22(14)2021 Jul 17.
Article in English | MEDLINE | ID: mdl-34299272

ABSTRACT

Breast cancer is the leading cause of mortality in women. It is a heterogeneous disease with a high degree of inter-subject variability even in patients with the same type of tumor, with individualized medicine having acquired significant relevance in this field. The clinical and morphological heterogeneity of the different types of breast tumors has led to a diversity of staging and classification systems. Thus, these tumors show wide variability in genetic expression and prognostic biomarkers. Surgical treatment is essential in the management of these patients. However, the perioperative period has been found to significantly influence survival and cancer recurrence. There is growing interest in the pro-tumoral effect of different anaesthetic and analgesic agents used intraoperatively and their relationship with metastatic progression. There is cumulative evidence of the influence of anaesthetic techniques on the physiopathological mechanisms of survival and growth of the residual neoplastic cells released during surgery. Prospective randomized clinical trials are needed to obtain quality evidence on the relationship between cancer and anaesthesia. This document summarizes the evidence currently available about the effects of the anaesthetic agents and techniques used in primary cancer surgery and long-term oncologic outcomes, and the biomolecular mechanisms involved in their interaction.


Subject(s)
Anesthetics/adverse effects , Breast Neoplasms/genetics , Breast Neoplasms/surgery , Animals , Breast Neoplasms/pathology , Female , Humans , Neoplasm Recurrence, Local/chemically induced , Neoplasm Recurrence, Local/genetics
7.
Molecules ; 26(23)2021 Nov 26.
Article in English | MEDLINE | ID: mdl-34885739

ABSTRACT

Transportation accounts for nearly one third of the total energy consumed worldwide and, unlike other sectors, it relies almost exclusively (96%) on petroleum [...].


Subject(s)
Biofuels , Transportation , Vehicle Emissions/prevention & control , Biomass , Greenhouse Effect , Humans , Petroleum/adverse effects
8.
Molecules ; 26(3)2021 Jan 22.
Article in English | MEDLINE | ID: mdl-33499286

ABSTRACT

To improve the thermochemical energy storage (TCS) behavior of Mn2O3, several Mn-Mo oxides with varying amounts of MoO3 (0-30 wt%) were prepared by a precipitation method. The physico-chemical properties of the solids were studied by N2 adsorption-desorption, X-ray diffraction (XRD), scanning electron microscopy (SEM), and H2-temperature-programmed reduction (TPR), while their TCS behavior was determined by thermogravimetric analysis coupled with differential scanning calorimetry (TGA-DSC). Apart from Mn2O3 and MoO3 phases, XRD revealed a mixed MnMoO4 phase for MoO3 loadings equal or higher than 1.5 wt%. All samples showed a well-formed coral-like surface morphology, particularly those solids with low MoO3 contents. This coral morphology was progressively decorated with compact and Mo-enriched MnMoO4 particles as the MoO3 content increased. TPR revealed that the redox behavior of Mn2O3 was significantly altered upon addition of Mo. The TCS behavior of Mn2O3 (mostly oxidation kinetics and redox cyclability) was enhanced by addition of low amounts of Mo (0.6 and 1.5% MoO3) without significantly increasing the reduction temperature of the solids. The coral morphology (which facilitated oxygen diffusion) and a smoother transition from the reduced to oxidized phase were suggested to be responsible for this improved TCS behavior. The samples containing 0.6 and 1.5 wt% of MoO3 showed outstanding cyclability after 45 consecutive reduction-oxidation cycles at high temperatures (600-1000 °C). These materials could potentially reach absorption efficiencies higher than 90% at concentration capacity values typical of concentrated solar power plants.


Subject(s)
Manganese Compounds/chemistry , Molybdenum/chemistry , Oxides/chemistry , Power Plants , Renewable Energy , Adsorption , Calorimetry, Differential Scanning , Catalysis , Microscopy, Electron, Scanning , Oxidation-Reduction , Solar Energy , Temperature , Thermogravimetry , X-Ray Diffraction
9.
Kidney Int ; 98(4): 1031-1043, 2020 10.
Article in English | MEDLINE | ID: mdl-32540404

ABSTRACT

Existing approaches for infection risk stratification in kidney transplant recipients are suboptimal. Here, we aimed to develop and validate a weighted score integrating non-pathogen-specific immune parameters and clinical variables to predict the occurrence of post-transplant infectious complications. To this end, we retrospectively analyzed a single-center derivation cohort of 410 patients undergoing kidney transplantation in 2008-2013 in Madrid. Peripheral blood lymphocyte subpopulations, serum immunoglobulin and complement levels were measured at one-month post-transplant. The primary and secondary outcomes were overall and bacterial infection through month six. A point score was derived from a logistic regression model and prospectively applied on a validation cohort of 522 patients undergoing kidney transplantation at 16 centers throughout Spain in 2014-2015. The SIMPLICITY score consisted of the following variables measured at month one after transplantation: C3 level, CD4+ T-cell count, CD8+ T-cell count, IgG level, glomerular filtration rate, recipient age, and infection within the first month. The discrimination capacity in the derivation and validation cohorts was good for overall (areas under the receiver operating curve of 0.774 and 0.730) and bacterial infection (0.767 and 0.734, respectively). The cumulative incidence of overall infection significantly increased across risk categories in the derivation (low-risk 13.7%; intermediate-risk, 35.9%; high-risk 77.6%) and validation datasets (10.2%, 28.9% and 50.4%, respectively). Thus, the SIMPLICITY score, based on easily available immune parameters, allows for stratification of kidney transplant recipients at month one according to their expected risk of subsequent infection.


Subject(s)
Kidney Transplantation , Humans , Kidney Transplantation/adverse effects , Retrospective Studies , Risk Factors , Spain/epidemiology , Transplant Recipients
10.
Clin Transplant ; 34(1): e13767, 2020 01.
Article in English | MEDLINE | ID: mdl-31815310

ABSTRACT

Tacrolimus is the cornerstone of immunosuppressive therapy after kidney transplantation. Its narrow therapeutic window mandates serum level strict monitoring and dose adjustments to ensure the optimal risk-benefit balance. This observational retrospective study analyzed the effectiveness and safety of conversion from twice-daily immediate-release tacrolimus (IR-Tac) or once-daily prolonged-release tacrolimus (PR-Tac) to the recent formulation once-daily MeltDose® extended-release tacrolimus (LCP-Tac) in 365 stable kidney transplant recipients. We compared kidney function three months before and three months after the conversion. Three months after conversion, the total daily dose was reduced ~35% (P < .0001), and improved bioavailability and stable serum LCP-Tac concentrations were observed. There was no increase in the number of patients requiring tacrolimus dose adjustments after conversion. Renal function was unaltered, and no cases of BPAR were reported. Reports of tremors, as collected in the clinical histories for each patient, decreased from pre-conversion (20.8%) to post-conversion (11.8%, P < .0001). LCP-Tac generated a cost reduction of 63% compared with PR-Tac. In conclusion, the conversion strategy to LCP-Tac from other tacrolimus formulations in stable kidney transplant patients showed safety and effectiveness in a real-world setting, confirming the data from RCTs. The specific pharmacokinetic properties of LCP-Tac could be potentially advantageous in patients with tacrolimus-related adverse events.


Subject(s)
Kidney Transplantation , Tacrolimus , Delayed-Action Preparations , Drug Administration Schedule , Humans , Immunosuppressive Agents/therapeutic use , Prospective Studies , Retrospective Studies
11.
Molecules ; 25(21)2020 Nov 09.
Article in English | MEDLINE | ID: mdl-33182450

ABSTRACT

Fossil fuels have been long used as a source of carbon for synthetizing the fuels, chemicals, and carbon-based materials we use on a daily basis [...].


Subject(s)
Biomass , Carbon/chemistry , Nitrogen/chemistry , Bioelectric Energy Sources , Biotransformation , Conservation of Energy Resources , Energy-Generating Resources , Fossil Fuels , Glycine max
12.
Molecules ; 25(4)2020 Feb 12.
Article in English | MEDLINE | ID: mdl-32059552

ABSTRACT

Concerns about depleting fossil fuels and global warming effects are pushing our society to search for new renewable sources of energy with the potential to substitute coal, natural gas, and petroleum. In this sense, biomass, the only renewable source of carbon available on Earth, is the perfect replacement for petroleum in producing renewable fuels. The aviation sector is responsible for a significant fraction of greenhouse gas emissions, and two billion barrels of petroleum are being consumed annually to produce the jet fuels required to transport people and goods around the world. Governments are pushing directives to replace fossil fuel-derived jet fuels with those derived from biomass. The present mini review is aimed to summarize the main technologies available today for converting biomass into liquid hydrocarbon fuels with a molecular weight and structure suitable for being used as aviation fuels. Particular emphasis will be placed on those routes involving heterogeneous catalysts.


Subject(s)
Biofuels , Biomass , Hydrocarbons/chemistry , Catalysis , Humans , Natural Gas
13.
Kidney Int ; 96(6): 1374-1380, 2019 12.
Article in English | MEDLINE | ID: mdl-31611066

ABSTRACT

Prediabetes and post-transplant diabetes mellitus affect about 20-30% of renal transplant patients. The latter is a risk factor for cardiovascular disease. However, no clear evidence linking prediabetes and cardiovascular disease is available. To study this we analyzed the impact of prediabetes on cardiovascular disease in 603 renal transplant patients followed with repeated oral glucose tests for up to five years and a long term survival evaluation. Prediabetes and post-transplant diabetes mellitus were defined at 12 months after transplantation to avoid their high reversibility rate before this period. 73 cardiovascular events were observed. The incidence of events was significantly higher in patients with either prediabetes, (17%; 0.023 person/year) or post-transplant diabetes mellitus (20%; 0.028 person/year) than in normal individuals, (7%; 0.0095 person/year). The incidence of events was comparable between prediabetes and post-transplant diabetes mellitus. Prediabetes at 12 months was a risk factor for cardiovascular events in univariate and multivariate Cox survival analyses (hazard ratio 2.24, 95% confidence interval 1.11-4.52). Prediabetes at three months and hemoglobin A1c at 12 months were not significantly associated with cardiovascular disease. Thus, prediabetes is a risk factor for cardiovascular disease in renal transplantation, a population at high risk for cardiovascular events. Since prediabetes is potentially a reversible condition, there is an opportunity to prevent cardiovascular disease in this population.


Subject(s)
Cardiovascular Diseases/etiology , Kidney Transplantation , Postoperative Complications/etiology , Prediabetic State/complications , Adult , Cardiovascular Diseases/metabolism , Cardiovascular Diseases/mortality , Female , Follow-Up Studies , Glucose/metabolism , Humans , Male , Middle Aged , Postoperative Complications/metabolism , Postoperative Complications/mortality , Prediabetic State/metabolism , Risk Factors , Spain/epidemiology
14.
J Nerv Ment Dis ; 207(6): 467-473, 2019 06.
Article in English | MEDLINE | ID: mdl-31045978

ABSTRACT

Wechsler Adult Intelligence Scale (WAIS) is one of the most widely used instruments to measure cognitive functioning. The aims of this study were 1) to obtain the cognitive profile of Spanish patients with schizophrenia on the WAIS-IV; 2) to compare their profile to the profile of a healthy control group; and 3) to compare the cognitive profile of patients with schizophrenia to the performance observed in two separate previous studies in Canada and China. A sample of 99 outpatients and 99 healthy control participants, matched on age, sex, and educational level, were measured using the WAIS-IV, including 10 core subtests, 4 indices, and 2 general intelligence scores, to obtain their cognitive profile. Results showed that only the performance on the Verbal Comprehension Index and its subtests was similar in the patient and control groups. This pattern of cognitive impairment was similar to the pattern reported in the Canadian and Chinese studies.


Subject(s)
Cognitive Dysfunction/physiopathology , Schizophrenia/physiopathology , Wechsler Scales , Adult , Cognitive Dysfunction/etiology , Female , Humans , Male , Middle Aged , Schizophrenia/complications
15.
Article in English | MEDLINE | ID: mdl-29229638

ABSTRACT

Saprochaete capitata, formerly known as Geotrichum capitatum, is an emerging fungal pathogen with low susceptibility to echinocandins. Here, we report the nucleotide sequence of the S. capitata hot spot 1 region of the FKS gene (FKS HS1), which codifies for the catalytic subunit of ß-1,3-d-glucan synthase, the target of echinocandins. For that purpose, we first designed degenerated oligonucleotide primers derived from conserved flanking regions of the FKS1 HS1 segment of 12 different fungal species. Interestingly, analysis of the translated FKS HS1 sequences of 12 isolates of S. capitata revealed that all of them exhibited the same F-to-L substitution in a position that is highly related to reduced echinocandin susceptibility.


Subject(s)
Antifungal Agents/pharmacology , Drug Resistance, Fungal/genetics , Echinocandins/pharmacology , Fungal Proteins/genetics , Gene Expression Regulation, Fungal , Geotrichum/genetics , Glucosyltransferases/genetics , Amino Acid Substitution , Base Sequence , DNA, Fungal/genetics , Fungal Proteins/metabolism , Geotrichosis/drug therapy , Geotrichosis/microbiology , Geotrichosis/pathology , Geotrichum/drug effects , Geotrichum/growth & development , Geotrichum/isolation & purification , Glucosyltransferases/metabolism , Humans , Microbial Sensitivity Tests , Protein Subunits/genetics , Protein Subunits/metabolism , Sequence Analysis, DNA
17.
Behav Res Methods ; 49(5): 1920-1929, 2017 10.
Article in English | MEDLINE | ID: mdl-27924442

ABSTRACT

This study presents a normative database of Spanish restricted length word stems that provides useful information for the selection of stimuli in memory experiments with Word Stem Completion (WSC) tasks. The database includes indices relative to stems (total baseline completion, priming baseline completion, priming, number of completions, ratio between given and deleted letters, and syllabic structure), and indices relative to characteristics of the words used to obtain the stems (frequency, familiarity, number of meanings, length, number of syllables, arousal, and valence). A WSC task was performed by 515 participants to calculate priming and baseline indices. An Exploratory Factor Analysis showed that these indices are grouped in four factors: perceptual, lexical, emotional, and response competition. Stepwise regression analyses performed with these factors showed that the lexical, response competition, and perceptual factors predict priming baseline completion, while only the lexical factor predicts priming. The model that best explains the relationship between priming and priming baseline completion was a cubic model, and the optimum baseline values for achieving priming were between .31 and .36. These norms can be downloaded as Supplemental Materials for this article from https://nuvol.uv.es/owncloud/index.php/s/hpj9by1qbENdjfj .


Subject(s)
Databases, Factual , Language , Memory , Vocabulary , Adolescent , Adult , Female , Humans , Male , Middle Aged , Spain , Young Adult
19.
Pharm Biol ; 54(11): 2623-2628, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27180996

ABSTRACT

CONTEXT: Tuberculosis is primarily caused by Mycobacterium tuberculosis (Mtb). Previous studies have shown that the dichloromethanic extract of Ambrosia confertiflora DC (Asteraceae) inhibited Mtb. OBJECTIVE: To isolate the compounds responsible for the mycobactericidal activity against clinical Mtb strains. MATERIALS AND METHODS: The dichloromethanic extract of aerial parts of A. confertiflora was separated using chromatography columns. Mycobactericidal activity of the isolated compounds was evaluated using the Alamar Blue bioassay (128-16 µg/mL, 7 days). Cytotoxicity was tested against normal cell line L929 using the MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium]) assay (100-3.125 µg/mL, 48 h). Compound structures were elucidated by 1H and 13C uni- and bidimensional NMR. RESULTS: Two sesquiterpene lactones (SQLs) with mycobactericidal activity were identified: santamarine and reynosin. Reynosin was the most active compound, with a minimal bactericidal concentration (MBC) of 128 µg/mL against the H37Rv, 366-2009 and 104-2010 Mtb strains and a minimal inhibitory concentration (MIC) of 64, 64, 128, 128 and 128 µg/mL against the H37Rv, 104-2010, 63-2009, 366-2009 and 430-2010 Mtb strains, respectively. Santamarine had MBCs of 128 µg/mL against the H3Rv and 104-2010 Mtb strains and MICs of 128 µg/mL against the H37Rv, 366-2009 and 104-2010 Mtb strains. We also isolated 1,10-epoxyparthenolide but only showed mycobacteriostatic activity (MIC 128 µg/mL) against the Mtb strain. Compounds were tested against the L929 cell line and the calculated selectivity index was <1. DISCUSSION AND CONCLUSIONS: This is the first report of the mycobactericidal activity of these compounds against clinical Mtb strains. It is also the first report of the isolation of 1,10-epoxyparthenolide from A. confertiflora. The anti-mycobacterial activity of A. confertiflora was attributed to the SQLs identified.


Subject(s)
Ambrosia/chemistry , Mycobacterium tuberculosis/drug effects , Sesquiterpenes/pharmacology , Humans , Microbial Sensitivity Tests
20.
BMC Complement Altern Med ; 15: 13, 2015 Feb 05.
Article in English | MEDLINE | ID: mdl-25652581

ABSTRACT

BACKGROUND: Cancer is one of the leading causes of death worldwide. Natural products have been regarded as important sources of potential chemotherapeutic agents. In this study, we evaluated the anti-proliferative activity of Argemone gracilenta's methanol extract and its fractions. We identified those compounds of the most active fractions that displayed anti-proliferative activity. METHODS: The anti-proliferative activity on different cancerous cell lines (M12.C3F6, RAW 264.7, HeLa) was evaluated in vitro using the MTT colorimetric method. Identification of the active compounds present in the fractions with the highest activity was achieved by nuclear magnetic resonance (NMR) and gas chromatography-mass spectrometry (GC-MS) analyses. RESULTS: Both argemonine and berberine alkaloids, isolated from the ethyl acetate fraction, displayed high anti-proliferative activity with IC50 values of 2.8, 2.5, 12.1, and 2.7, 2.4, 79.5 µg/mL on M12.C3F6, RAW 264.7, and HeLa cancerous cell lines, respectively. No activity was shown on the normal L-929 cell line. From the hexane fraction, a mixture of fatty acids and fatty acid esters of 16 or more carbon atoms with anti-proliferative activity was identified, showing a range of IC50 values of 16.8-24.9, 34.1-35.4, and 67.6-91.8 µg/mL on M12.C3F6, RAW 264.7, and HeLa cancerous cell lines, respectively. On the normal L-929 cell line, this mixture showed a range of IC50 values of 85.1 to 100 µg/mL. CONCLUSION: This is the first study that relates argemonine, berberine, and a mixture of fatty acids and fatty acid esters with the anti-proliferative activity displayed by Argemone gracilenta.


Subject(s)
Alkaloids/therapeutic use , Antineoplastic Agents, Phytogenic/therapeutic use , Argemone/chemistry , Fatty Acids/therapeutic use , Phytotherapy , Plant Extracts/therapeutic use , Uterine Cervical Neoplasms/drug therapy , Alkaloids/analysis , Alkaloids/isolation & purification , Alkaloids/pharmacology , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Berberine/isolation & purification , Berberine/pharmacology , Berberine/therapeutic use , Bridged Bicyclo Compounds, Heterocyclic/analysis , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Bridged Bicyclo Compounds, Heterocyclic/therapeutic use , Cell Line , Fatty Acids/analysis , Fatty Acids/pharmacology , Female , Gas Chromatography-Mass Spectrometry , HeLa Cells , Humans , In Vitro Techniques , Mice , Plant Extracts/chemistry , Plant Extracts/pharmacology , Tetrahydroisoquinolines/analysis , Tetrahydroisoquinolines/pharmacology , Tetrahydroisoquinolines/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL